| # | Drug | Count |
|---|---|---|
| 0 | VORICONAZOLE | 21 |
| 1 | VORICONAZOLE INJECTION | 21 |
| 2 | TACROLIMUS | 19 |
| 3 | PREDNISONE | 18 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 18 |
| 5 | TACROLIMUS OINTMENT 0.1% | 18 |
| 6 | MYCOPHENOLATE MOFETIL | 16 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 16 |
| 8 | COLCHICINE | 7 |
| 9 | OCTREOTIDE ACETATE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RILONACEPT | 1 | 0.0009 |
| 1 | VORICONAZOLE | 21 | 0.0007 |
| 2 | DALTEPARIN SODIUM | 5 | 0.0005 |
| 3 | AMIFAMPRIDINE PHOSPHATE | 1 | 0.0003 |
| 4 | TOPOTECAN | 2 | 0.0003 |
| 5 | COLCHICINE | 7 | 0.0003 |
| 6 | CRIZOTINIB | 3 | 0.0002 |
| 7 | OCTREOTIDE ACETATE | 7 | 0.0002 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 9 | CANAKINUMAB | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Azole Antifungal [EPC] | 21 |
| 1 | Corticosteroid [EPC] | 21 |
| 2 | Factor Xa Inhibitor [EPC] | 8 |
| 3 | Kinase Inhibitor [EPC] | 8 |
| 4 | Alkaloid [EPC] | 7 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 7 |
| 6 | Platinum-based Drug [EPC] | 7 |
| 7 | Alkylating Drug [EPC] | 5 |
| 8 | Microtubule Inhibitor [EPC] | 5 |
| 9 | Loop Diuretic [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 2 | Alkaloid [EPC] | 7 | 0.0003 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 4 | Azole Antifungal [EPC] | 21 | 0.0001 |
| 5 | Interleukin-1 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |